Clinical and cost-effectiveness analysis of mFOLOFX6 with or without a targeted drug among patients with metastatic colorectal cancer: inverse probability of treatment weighting.
Am J Cancer Res
; 13(9): 4039-4056, 2023.
Article
in En
| MEDLINE
| ID: mdl-37818063
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Aspects:
Patient_preference
Language:
En
Journal:
Am J Cancer Res
Year:
2023
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Estados Unidos